Keloids
14
2
3
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
2 terminated out of 14 trials
75.0%
-11.5% vs benchmark
36%
5 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
Keloid Pathogenesis And Fibroblast Activation Study
Scar Gel Product Family Clinical Investigation
Comparison Of Effectiveness Of Intralesional Injectioms Of 5 Flourouracil Alone Verses Its Cpmbination With Cryotherapy In The Treatment Of Keloids
A Prospective Observational Clinical Study on Exploring the Value of Surgical Excision Combined With 32P Application in the Treatment of Keloids and the Factors Affecting the Prognosis of Combined Therapy
Efficacy and Safety of Intralesional 5-Fluorouracil and Triamcinolone Acetonide in Keloids and Hypertrophic Scars
Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.
Silicone vs Pirfenidone in the Treatment of Hypertrophic Scars and Keloids
Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence
Sorafenib for Patients With Extensive Keloids
Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser
UVA1 Light for Treatment of Scleroderma and Similar Conditions
Scars After Central Venous Catheters
Effect of Transparent, Self-drying Silicone Gel on the Treatment of Hypertrophic Abdominal Scars
CICATRIX in the Treatment of Hypertrophic Scars and Keloids Scars